Imuldosa

Active Ingredient(s): Ustekinumab-srlf
FDA Approved: * October 10, 2024
Pharm Company: * ACCORD BIOPHARMA INC.
Category: Immunosuppressive

Ustekinumab, sold under the brand name Stelara is a monoclonal antibody medication developed by Janssen Pharmaceuticals, for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis,[5] targeting both IL-12 and IL-23.[6] Ustekinumab is approved to treat Crohn's disease in the United States, Israel, Australia, and the European Union (EU), and ulcerative colitis in the US, and in the EU to patients who have not responded to m... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Imuldosa 45 mg/.5ml Subcutaneous Injection
NDC: 51407-929
Labeler:
Golden State Medical Supply, Inc.
Imuldosa 90 mg/ml Subcutaneous Injection
NDC: 51407-930
Labeler:
Golden State Medical Supply, Inc.
Imuldosa 130 mg/26ml Intravenous Injection
NDC: 51407-931
Labeler:
Golden State Medical Supply, Inc.
Imuldosa 45 mg/.5ml Subcutaneous Injection
NDC: 69448-017
Labeler:
Accord Biopharma Inc.
Imuldosa 90 mg/ml Subcutaneous Injection
NDC: 69448-018
Labeler:
Accord Biopharma Inc.
Imuldosa 130 mg/26ml Intravenous Injection
NDC: 69448-019
Labeler:
Accord Biopharma Inc.

Related Brands

Drugs with the same active ingredients